Unlock Premium Data: Up to 50% Off InvestingProCLAIM SALE

UPDATE 2-Canexus, Chemtrade in friendly talks after hostile bid

Published 2016-12-13, 04:48 p/m
© Reuters.  UPDATE 2-Canexus, Chemtrade in friendly talks after hostile bid
CNQ
-
CUS
-
SPB
-
CHE_u
-

(Adds confirmation from company, updates stock price)

By John Tilak

TORONTO, Dec 13 (Reuters) - Canadian chemical company Canexus Corp CUS.TO , which rejected a hostile bid from Chemtrade Logistics Income Fund CHE_u.TO , confirmed on Tuesday that it is in talks with the company about a higher offer.

Chemtrade, a supplier of industrial chemicals, has increased its takeover offer to C$1.65 per share, Canexus said in a statement. Reuters had earlier reported the discussions.

Canexus rebuffed a C$1.50-per-share unsolicited offer in October, saying the C$297.2 million bid undervalued the company. Chemtrade initially offered C$1.45 per share. The stock closed at C$1.62 on Tuesday.

There is no assurance that the discussions will result in a deal, both companies said in separate statements.

A deal for Canexus to be acquired by Canadian chemical maker Superior Plus Corp SPB.TO fell through earlier this year.

Calgary-based Canexus has come under pressure from different quarters. Stirling Funds, a major shareholder, criticized Canexus for not considering the Chemtrade offer.

In September, Stirling released an open letter saying Canexus "has ostensibly not explored this interest and rather it has embarked on a convertible debenture making the company less attractive to potential suitors thereby destroying shareholder value."

Stirling owns 14.2 percent of Canexus, according to Thomson Reuters data, and has been boosting its stake.

Further, Stirling has requisitioned a shareholder meeting, calling for the replacement of the current board with its own slate.

Murray Edwards, executive chairman of Canadian Natural Resources Ltd CNQ.TO , also has shown interest in Canexus shares during this time.

Edwards had been increasing his stake in Canexus since the Chemtrade bid and owned about 9.5 percent of Canexus, he said in a statement in October.

Canexus had a total net debt of about C$538 million at the end of the third quarter, when it also posted a net loss.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.